Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Legal & Privacy Officer | June 09, 2022 | July 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date June 09, 2022 · Filed July 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,130 |
Ending reported balance
After 2022-07-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130 F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 7,812 |
Reported balance
After 2022-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812 F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 900 | $130.36 | $117,324.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,009 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $129.89 to $130.77, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 600 | $129.17 | $77,502.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,909 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $128.84 to $129.60, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,800 | $128.18 | $230,724.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,509 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $127.67 to $128.63, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,900 | $127.10 | $241,490.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,309 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $126.67 to $127.54, inclusive. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 21:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,500 | $126.04 | $315,100.00 |
DisclosureSEC source: 0001666071-21-000036 · wf-form4_161558394308757.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,209 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.67 to $126.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 100 | $158.95 | $15,895.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 10 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,709 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 300 | $157.92 | $47,376.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 9 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,809 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F10 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $157.44 to $158.29, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 475 | $156.32 | $74,252.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,109 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F9 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $156.14 to $156.58, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,600 | $155.64 | $249,024.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,584 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F8 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $155.11 to $156.10, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 900 | $154.60 | $139,140.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,184 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $154.10 to $155.02, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 700 | $153.29 | $107,303.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,084 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $153.03 to $153.79, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,765 | $152.46 | $421,551.90 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,784 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.94, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 500 | $151.41 | $75,705.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,549 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $150.93 to $151.91, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 860 | $150.37 | $129,318.20 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,049 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $149.89 to $150.75, inclusive. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 200 | $149.18 | $29,836.00 |
DisclosureSEC source: 0001666071-21-000009 · wf-form4_161316837224100.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,909 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $148.73 to $149.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9) and (10) to this Form 4. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 00:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,074 | $146.36 | $157,190.64 |
DisclosureSEC source: 0001666071-21-000005 · wf-form4_161058546507723.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,109 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $146.14 to $146.60, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 00:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,185 | $145.73 | $318,420.05 |
DisclosureSEC source: 0001666071-21-000005 · wf-form4_161058546507723.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,183 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $145.14 to $146.13, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 00:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,388 | $144.55 | $345,185.40 |
DisclosureSEC source: 0001666071-21-000005 · wf-form4_161058546507723.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,368 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $144.09 to $145.02, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 00:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,953 | $143.73 | $280,704.69 |
DisclosureSEC source: 0001666071-21-000005 · wf-form4_161058546507723.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,756 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $143.07 to $144.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 722 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-21-000002 · wf-form4_161005408064554.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,185 Underlying: Common Stock · 722 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F3 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 261 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000002 · wf-form4_161005408064554.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 261 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 983 | $135.08 | $132,783.64 |
DisclosureSEC source: 0001666071-21-000002 · wf-form4_161005408064554.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,709 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 722 | $30.44 | $21,977.68 |
DisclosureSEC source: 0001666071-21-000002 · wf-form4_161005408064554.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:14 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 261 | $20.00 | $5,220.00 |
DisclosureSEC source: 0001666071-21-000002 · wf-form4_161005408064554.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 300 | $136.00 | $40,800.00 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,709 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F10 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.99 to $136.00, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,960 | $135.00 | $399,600.00 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,009 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F9 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.50 to $135.43, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 203 | $133.70 | $27,141.10 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,969 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F8 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $133.45 to $133.95, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $132.85 | $398,550.00 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,172 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $132.36 to $133.35, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,601 | $131.78 | $210,979.78 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,172 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.18, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,961 | $130.80 | $779,698.80 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,773 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $130.33 to $131.26, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,431 | $129.95 | $705,758.45 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,734 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $129.33 to $130.32, inclusive. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,169 | $128.81 | $279,388.89 |
DisclosureSEC source: 0001666071-20-000307 · wf-form4_160824216401396.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,165 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2020. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $128.30 to $129.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7), (8), (9) and (10) to this Form 4. F3 · balance_after: Includes 175 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000300 · wf-form4_160694427427969.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,159 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 174 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000300 · wf-form4_160694427427969.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,359 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000300 · wf-form4_160694427427969.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,533 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:24 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000300 · wf-form4_160694427427969.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,583 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 22:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 50 | $120.63 | $6,031.50 |
DisclosureSEC source: 0001666071-20-000299 · wf-form4_160677436011799.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,683 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on November 25, 2020. F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.63 to $120.66, inclusive. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 22:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 2,000 | $119.77 | $239,540.00 |
DisclosureSEC source: 0001666071-20-000299 · wf-form4_160677436011799.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,733 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on November 25, 2020. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.32, inclusive. Read SEC document |
| November 27, 2020 Filed Nov 30, 2020 22:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,585 | $118.84 | $188,361.40 |
DisclosureSEC source: 0001666071-20-000299 · wf-form4_160677436011799.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,733 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for PSUs that vested on November 25, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $118.31 to $119.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 22:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000299 · wf-form4_160677436011799.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on November 25, 2020, 12 months after the Certification. F6 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019. Twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on May 25, 2020, 6 months after the Certification. The final twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU vested on November 25, 2020, 12 months after the Certification. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 22:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 7,812 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000299 · wf-form4_160677436011799.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:41 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 778 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000291 · wf-form4_160590846349707.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 778 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:41 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 778 | $20.00 | $15,560.00 |
DisclosureSEC source: 0001666071-20-000291 · wf-form4_160590846349707.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · derivative · entry 9 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: The RSUs are immediately vested. F6 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · derivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420 Underlying: Common Stock · 420 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F6 · derivative.exercise_date: The RSUs are immediately vested. F6 · derivative.expiration_date: The RSUs are immediately vested. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,906 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · derivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,907 Underlying: Common Stock · 3,906 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,562 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · derivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 Underlying: Common Stock · 1,562 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 172 | $100.27 | $17,246.44 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,728 F2 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on November 9, 2020. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 01:47 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 3,906 | $30.44 | $118,898.64 |
DisclosureSEC source: 0001666071-20-000286 · wf-form4_160505925820716.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.